A rare treatable cause of levodopa unresponsive generalized dystonia

A rare treatable cause of levodopa unresponsive generalized dystonia

Saved in:

Bibliographic Details
Main Authors:	Kavya L. Akshinthala, Sireesha Yareeda, Gowri Shankar Barathidasan, Reshma Sultana Shaik
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Annals of Movement Disorders
Online Access:	https://doi.org/10.4103/aomd.aomd_32_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Baraitser Winter Syndrome – A Rare Deep Brain Stimulation (DBS) Responsive Dystonia!
by: Sireesha Yareeda, et al.
Published: (2024-12-01)

SLC39A14 Deficiency: A Rare Cause of Treatable Infantile Neuroregression
by: Singanamalla Bhanudeep, et al.
Published: (2024-12-01)

Propionibacterium acnes: A Treatable Cause of Constrictive Pericarditis
by: Daniel Cruz, et al.
Published: (2015-01-01)

Strategies to Overcome Antileishmanial Drugs Unresponsiveness
by: Shyam Sundar, et al.
Published: (2014-01-01)

A Treatable Mimicker of Cholangiocarcinoma
by: Malcolm Wells, et al.
Published: (2015-01-01)

Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy
by: Lucinda Barry, et al.
Published: (2021-01-01)

Renovascular Mistaken as Essential Hypertension due to Giant Hepatic Hydatid: A Rare Treatable Entity
by: Awaji Qasim Alnami, et al.
Published: (2018-01-01)

When Should Naloxone Be Administered to the Undifferentiated Unresponsive Person?
Published: (2018-08-01)

Advances in neuromodulation for treatment of dystonia
by: LIANG Nan, et al.
Published: (2025-01-01)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
by: Nicola Tambasco, et al.
Published: (2012-01-01)

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
by: Cindy Zadikoff, et al.
Published: (2020-01-01)

Tardive Dystonia: Clinical Spectrum and Novel Manifestations
by: R. Jeffrey Davis, et al.
Published: (1988-01-01)

Dystonia caused by ANO3 variants is due to attenuated Ca2+ influx by ORAI1
by: Jiraporn Ousingsawat, et al.
Published: (2025-01-01)

Adult-Onset Idiopathic Cervical Dystonia
by: Shameer Rafee, et al.
Published: (2022-12-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Inherited metabolic disorders… …do not miss treatable diseases…
by: Maria Giżewska
Published: (2024-04-01)

Vitreous Decompression Combined with Phacoemulsification for Medically Unresponsive Acute Angle Closure
by: Xiaoli Xiang, et al.
Published: (2021-01-01)

Somatosensory Evoked Potentials and Dopaminergic Responsiveness to Apomorphine and Levodopa in Parkinsonian Patients
by: M. Miranda, et al.
Published: (1996-01-01)

Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)

Clinical practice guidelines on addressing cognitive impairment in treatable dementias
by: M Aleem Siddiqui, et al.
Published: (2025-01-01)

A Treatable Neurometabolic Disorder: Glutaric Aciduria Type 1
by: S. Pusti, et al.
Published: (2014-01-01)

Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review
by: Tarun Girotra, et al.
Published: (2017-01-01)

The Parkinson’s Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge
by: Dávid Pintér, et al.
Published: (2019-01-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)

Nanocarriers-Assisted Nose-to-Brain Delivery of Levodopa: Current Progress and Prospects
by: Mariya Dangova, et al.
Published: (2024-12-01)

Research on Role of Connexin 36 in Pathogenesis of Rats with Levodopa-induced Dyskinesia
by: Bingtian ZHANG, et al.
Published: (2016-08-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Isolated Idiopathic Cervical Dystonia with a Rare Type of Atlantoaxial Dislocation. A Case Report and a Short Literature Review
by: Aldakheel DA
Published: (2025-02-01)

Bench Scale Treatability Studies of Contaminated Soil Using Soil Washing Technique
by: M. K. Gupta, et al.
Published: (2010-01-01)

Pelvic Radiotherapy in Rectal Cancer Patients With Synchronous Potentially Treatable Liver Metastases
by: Yayu Huang, et al.
Published: (2025-01-01)

Asymmetric Central Processing of Sensory Stimuli in Idiopathic Focal Dystonia
by: R. A. Grünewald, et al.
Published: (1997-01-01)

Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia
by: Graciela Kriegel, et al.
Published: (2019-01-01)

The Mechanisms of Movement Control and Time Estimation in Cervical Dystonia Patients
by: Pavel Filip, et al.
Published: (2013-01-01)

A Beautician’s Dystonia: Long-Lasting Effect of Botulinum Toxin
by: Siria Di Martino, et al.
Published: (2014-01-01)

Successful Pallidal Deep Brain Stimulation Treatment in a Case of Generalized Dystonia due to a Novel ANO3 Mutation
by: Lizl Lasky, et al.
Published: (2019-01-01)

Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study
by: Oriol De Fabregues, et al.
Published: (2018-01-01)

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Osamu Kano, et al.
Published: (2022-01-01)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
by: Haruo Nishijima, et al.
Published: (2018-01-01)

Determination of Biological Treatability Processes of Textile Wastewater and Implementation of a Fuzzy Logic Model
by: Harun Akif Kabuk, et al.
Published: (2015-01-01)

Resolution of Decerebrate Posturing from Paroxysmal Autonomic Instability with Dystonia Syndrome
by: Dhanush Anand, et al.
Published: (2025-01-01)